Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions

Anaïs Schavgoulidze; Aurore Perrot; Titouan Cazaubiel; Xavier Leleu; Lydia Montes; Caroline Jacquet; Karim Belhadj; Sabine Brechignac; Laurent Frenzel; Thomas Chalopin; Philippe Rey; Jean-Marc Schiano de Collela; Mamoun Dib; Denis Caillot; Margaret Macro; Jean Fontan; Laure Buisson; Luka Pavageau; Murielle Roussel; Salomon Manier; Mohamad Mohty; Ludovic Martinet; Hervé Avet-Loiseau; Jill Corre

doi:10.1038/s41408-023-00933-4

Prognostic impact of translocation t(14;16) in multiple myeloma according to the presence of additional genetic lesions

Blood Cancer J. 2023 Oct 26;13(1):160. doi: 10.1038/s41408-023-00933-4.

Authors

Anaïs Schavgoulidze^{1

2}, Aurore Perrot^{2

3}, Titouan Cazaubiel⁴, Xavier Leleu⁵, Lydia Montes⁶, Caroline Jacquet⁷, Karim Belhadj⁸, Sabine Brechignac⁹, Laurent Frenzel¹⁰, Thomas Chalopin¹¹, Philippe Rey¹², Jean-Marc Schiano de Collela¹³, Mamoun Dib¹⁴, Denis Caillot¹⁵, Margaret Macro¹⁶, Jean Fontan¹⁷, Laure Buisson^{1

2}, Luka Pavageau^{1

2}, Murielle Roussel¹⁸, Salomon Manier¹⁹, Mohamad Mohty²⁰, Ludovic Martinet², Hervé Avet-Loiseau^{1

2}, Jill Corre^{21

22}

Affiliations

¹ Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole, Toulouse, France.
² Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France.
³ Hematology Department, IUCT-Oncopole, Toulouse, France.
⁴ Hematology Department, University Hospital, Bordeaux, France.
⁵ Hematology Department, University Hospital, Poitiers, France.
⁶ Hematology Department, University Hospital, Amiens, France.
⁷ Hematology Department, University Hospital, Nancy, France.
⁸ Hematology Department, University Hospital, Créteil, France.
⁹ Hematology Department, University Hospital, Bobigny, France.
¹⁰ Hematology Department, Necker University Hospital, Paris, France.
¹¹ Hematology Department, University Hospital, Tours, France.
¹² Hematology Department, Centre Léon Bérard, Lyon, France.
¹³ Hematology Department, Institut Paoli Calmettes, Marseille, France.
¹⁴ Hematology Department, University Hospital, Angers, France.
¹⁵ Hematology Department, Institut de Cancérologie de Bourgogne, Dijon, France.
¹⁶ Hematology Department, University Hospital, Caen, France.
¹⁷ Hematology Department, University Hospital, Besançon, France.
¹⁸ Hematology Department, University Hospital, Limoges, France.
¹⁹ Hematology Department, University Hospital, Lille, France.
²⁰ Hematology Department, Saint-Antoine University Hospital, Paris, France.
²¹ Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole, Toulouse, France. corre.jill@iuct-oncopole.fr.
²² Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France. corre.jill@iuct-oncopole.fr.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Chromosomes, Human, Pair 14 / genetics
Humans
In Situ Hybridization, Fluorescence
Multiple Myeloma* / genetics
Multiple Myeloma* / pathology
Prognosis
Translocation, Genetic

Grants and funding

P50 CA100707/CA/NCI NIH HHS/United States